Perrigo Company plc (PRGO) Stock

Perrigo Company plc (PRGO) is a Healthcare stock trading at $10.24 (as of 2026-06-18), with a market capitalization of $1.53B and a trailing P/E of -0.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Perrigo Company plc develops, manufactures, markets, and sells over-the-counter consumer health and self-care products. It operates in the Consumer Self-Care Americas and Consumer Self-Care International segments, serving customers through retail and pharmacy channels in the Americas and in approximately 23 countries, primarily in Europe.

Valuation — source: SEC EDGAR (first-party)
Price	$10.24
Market Cap	$1.53B
P/E Ratio	-0.8
EV / EBITDA	-4.0
Price / Book	0.61
Price / Sales	0.37
Dividend Yield	10.4%
DCF Value (model)	$4.01
DCF Upside vs Price	-60.9%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$4.25B
Net Margin	-33.5%
Return on Equity	-72.7%
Debt / Equity	1.45
Current Ratio	2.72
Revenue Growth (YoY)	-2.8%
EPS Growth (YoY)	723.2%
FCF Growth (YoY)	-40.7%

Financial Health — source: SEC EDGAR
Altman Z-Score	-0.14 (distress)
Piotroski F-Score	4/9 (moderate)

Valuation vs Sector & Industry
Stock P/E	-0.8
Sector P/E (Healthcare)	21.0
Industry P/E (Pharmaceutical Products)	17.3
vs Sector	-104.0%
vs Industry	-104.9%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BlackRock Fund Advisors ($235.93M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Patrick Lockwood-Taylor
Employees	8,379
Country	IE
IPO Date	1991-12-17

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.